The COPD Foundation has expanded its excellent COPD 101 Library again. It is an excellent overview of key clinical concepts for COPD & Genetic COPD, including risk factors, epidemiology, screening and diagnostics, and treatment strategies. This presentation can be a starting point for anyone new to COPD or seeking to improve overall care. Patient education materials, created specifically to assist clear communication of disease management concepts, are also included to help optimize therapy plans.
Friday, April 5, 2024
Wednesday, April 3, 2024
Reducing Price of Inhaled Drugs
Boehringer Ingelheim, AstraZeneca and Glaxo Smith Kline have announced that they will begin limiting out-of-pocket costs for inhalers for eligible patients to $35/month.
This program will start on June 1, 2024 at retail pharmacies. This price cap does not apply to government-sponsored health plans such as Medicare, Medicaid, or VA benefits.
Subscribe to:
Posts (Atom)